PUBLISHER: Allied Market Research | PRODUCT CODE: 1193299
PUBLISHER: Allied Market Research | PRODUCT CODE: 1193299
The global fatty bases for suppositories market is envisioned to garner $339.5 million by 2031, growing from $197.9 million in 2021, at a CAGR of 5.59% from 2022 to 2031.
A suppository is a solid form of medication that is intended to be inserted into bodily cavities other than the mouth. They can be inserted in the vaginal canal, rectum, or urethra. After being inserted, the objects melt or dissolve in the fluids of the cavity, releasing the medicines. Rectal, vaginal, and urethral suppositories are available, each with a different insertion location. These medicines also have an effect locally. Additionally, there is no first-pass action, which stops the drug's metabolism. Drugs that are bitter or offensive can be delivered effectively using suppositories. Suppositories are frequently used in paediatric medicine to address constipation-related symptoms.
Primarily in pediatric and geriatric patients, the fat-based excipients play a significant role in drug delivery. For drug delivery among pediatric and geriatric populations, the rectal route is a great alternative. Over the anticipated period, the market growth is anticipated to be aided by the rising demand for fat-based suppositories due to their benefits, including the quick absorption of several low molecular weight drugs and the potential for lymphatic system absorption. Although fatty bases for suppositories have a long history of use in rectal and vaginal drug delivery, the current global market for these products is constrained primarily by a lack of consumer acceptance and willingness to use rectal products. Additionally, it is thought that the difficulties in producing oil-based suppositories will somewhat restrain the market expansion.
The fatty basses for suppositories market is being driven by rising healthcare expenditure in developed countries and an ageing population. In these populations, the rectal route is an ideal choice for medication delivery. Growing demand for suppositories is likely to support market expansion over the forecast period due to benefits such as quick absorption of certain low molecular weight pharmaceuticals and the possibility of absorption into the lymphatic system. The suppositories sector is expected to rise as a result of improved physical and chemical stability, neutrality toward mucosal membranes, and full compatibility with almost all active compounds. This helps to the global fatty bases for suppositories market growth. These factors are further expected to propel the global fatty bases suppositories market growth.
During the COVID-19 pandemic surge, self-medication was a common practice for taking medications. Numerous treatment facilities and clinics with just single doctor had to close due to the pandemic, depriving the general public of timely medical care. The pandemic has encouraged self-medication. Topical corticosteroids were the self-medication methods that were most widely used. The most widely used topical drugs included anti-acne drugs, corticosteroids, combos (corticosteroids, antibiotics, and antifungals), moisturizers, and suppositories. The rise in demand for over-the-counter and topical medications brought on by self-medication has benefited the market for suppositories.
The key players profiled in this report include Unither, Bliss GVS Pharma Ltd., Delpharm, ATRAL, Aenova Holding GmBH, FAMAR, LGV (Laboratories Mayoly Spindler), and Priyans Drugs.
Key Benefits For Stakeholders
By Base Type
By Region